These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6500451)

  • 1. [Hemorheologic therapy in peripheral arterial occlusive disease].
    Kiesewetter H; Jung F
    Fortschr Med; 1984 Oct; 102(37):921-4. PubMed ID: 6500451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative drug therapy and walking exercise in stage IIb peripheral arterial occlusion disease.
    Kiesewetter H; Jung F; Blume J; Bulling B; Gerhards M
    Klin Wochenschr; 1986 Oct; 64(20):1061-9. PubMed ID: 2431197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
    Angelkort B
    Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
    Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
    Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
    Weidinger P; Bilek M; Tekusch A
    Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
    [No Abstract]   [Full Text] [Related]  

  • 6. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
    Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current therapy of peripheral arterial occlusive diseases in the aged].
    Schütz RM
    Z Gerontol; 1992; 25(2):101-4. PubMed ID: 1609537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic consequences of hemorheologic research].
    Ernst E
    Wien Med Wochenschr; 1989 Dec; 139(24):569-80. PubMed ID: 2696217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overview of the most frequent clinical manifestations of peripheral arterial occlusive disease in the elderly, its diagnosis and stage-related therapy].
    Ebert D
    Z Arztl Fortbild Qualitatssich; 1997 Sep; 91(6):525-31. PubMed ID: 9441027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normovolemic hemodilution in peripheral arterial disease.
    Rieger H; Köhler M; Schoop W; Schmid-Schönbein H
    Ann Clin Res; 1981; 13 Suppl 33():78-83. PubMed ID: 7342848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy from the hemorheologic viewpoint. 1: Hemodilution and defibrinogenation].
    Ernst E
    Fortschr Med; 1986 Jun; 104(21):423-6. PubMed ID: 3732982
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemorheologic studies for evaluating microcirculation in patients with peripheral arterial circulatory disorders and diabetes mellitus].
    Sternitzky R; Hänsgen K; Podhaisky H; Frank I; Klare M; Preuss EG
    Z Gesamte Inn Med; 1986 Oct; 41(19):539-42. PubMed ID: 3811440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodilution in peripheral arterial occlusive disease].
    Becsi C; Wehofer D; Weidinger P
    Vasa Suppl; 1988; 26():113-5. PubMed ID: 2462284
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
    Turowski A; Schmidt HH; Sternitzky R
    Z Arztl Fortbild (Jena); 1987; 81(17):883-8. PubMed ID: 3439205
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypervolemic hemodilution with or without venesection in peripheral arterial occlusive disease stage II.
    Kiesewetter H; Jung F; Birk A; Spitzer S
    Int Angiol; 1994 Mar; 13(1):1-4. PubMed ID: 8077790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypervolemic hemodilution with bloodletting in patients with peripheral arterial occlusive disease].
    Kiesewetter H; Blume HJ; Jung F; Bach R; Spitzer S; Leipnitz G; Schieffer H; Bette L; Wenzel E
    Vasa Suppl; 1988; 26():107-12. PubMed ID: 2462283
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Bach R; Birk A; Schieffer H; Wenzel E
    Schweiz Med Wochenschr; 1989 Dec; 119(51):1862-7. PubMed ID: 2481883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Induced hemodilution as a new concept in the therapy of peripheral circulatory disorders].
    Rieger H
    Internist (Berl); 1982 Jul; 23(7):375-82. PubMed ID: 7049999
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood rheological changes and their clinical significance in chronic arterial obstructive disease].
    Sternitzky R; Seige K
    Z Gesamte Inn Med; 1983 Jan; 38(1):1-7. PubMed ID: 6342278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.